Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy
Article in Cancer Research Communications (July 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Cancer Research Communications (July 2023)
Preprint in Research Square (November 2022)
Article in International Journal of Molecular Sciences (August 2022)